Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07348510

Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures

Comparison Between the Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This work aims to investigate the diuretic effect of Aminophylline in comparison to Furosemide in adult patients undergoing cardiac surgical procedures.

Detailed description

Acute Kidney injury (AKI) is a serious and common complication after either adult or pediatric cardiac surgery. The results of a recent meta-analysis suggested that loop diuretics (furosemide) may reduce postoperative creatinine clearance, whereas aldosterone agonists (spironolactone) increase the incidence of cardiac surgery-associated acute kidney injury (CSA-AKI). Diuretics are not recommended for the prevention of AKI, but loop diuretics may be used for the management of volume overload Aminophylline in cardiac surgery can reduce the frequency of AKI and could be used in the prevention of AKI as a safe and efficient modality in high-risk patients.

Conditions

Interventions

TypeNameDescription
DRUGAminophyllinePatients will receive Aminophylline.
DRUGFurosemidePatients will receive furosemide.

Timeline

Start date
2026-01-17
Primary completion
2026-07-26
Completion
2026-07-26
First posted
2026-01-16
Last updated
2026-01-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07348510. Inclusion in this directory is not an endorsement.